연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1749 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Yang, Keungmo | Yang, K | 5 | Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Yang, Keungmo | Yang, K | 5 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Kim, Bohyun | Kim, B | 6 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Choi, Joon-Il | Choi, JI | 7 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Jang, Jeong Won | Jang, JW | 8 | Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea | LOS-2890-2024 | Jang, Jeong | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Jang, Jeong Won | Jang, JW | 8 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea | LOS-2890-2024 | Jang, Jeong | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Choi, Jong Young | Choi, JY | 9 | Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Choi, Jong Young | Choi, JY | 9 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Yoon, Seung Kew | Yoon, SK | 10 | Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Yoon, Seung Kew | Yoon, SK | 10 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | |||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Han, Ji Won | Han, JW | 11 | 교신저자 | Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | ||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Han, Ji Won | Han, JW | 11 | 교신저자 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea | tmznjf@catholic.ac.kr;pssung49@gmail.com; | ||||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Sung, Pil Soo | Sung, PS | 12 | 교신저자 | Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea | K-2072-2019 | Sung, Pil | tmznjf@catholic.ac.kr;pssung49@gmail.com; | ||
| Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab | Sung, Pil Soo | Sung, PS | 12 | 교신저자 | Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea | K-2072-2019 | Sung, Pil | tmznjf@catholic.ac.kr;pssung49@gmail.com; | ||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Lee, Soo Jung | Lee, SJ | 1 |
페이지 이동: